Abstract
AIMS: Mutation detection accuracy has been described extensively; however, it is surprising that pre-PCR processing of formalin-fixed paraffin-embedded (FFPE) samples has not been systematically assessed in clinical context. We designed a RING trial to (i) investigate pre-PCR variability, (ii) correlate pre-PCR variation with EGFR/BRAF mutation testing accuracy and (iii) investigate causes for observed variation.
METHODS: 13 molecular pathology laboratories were recruited. 104 blinded FFPE curls including engineered FFPE curls, cell-negative FFPE curls and control FFPE tissue samples were distributed to participants for pre-PCR processing and mutation detection. Follow-up analysis was performed to assess sample purity, DNA integrity and DNA quantitation.
RESULTS: Rate of mutation detection failure was 11.9%. Of these failures, 80% were attributed to pre-PCR error. Significant differences in DNA yields across all samples were seen using analysis of variance (p<0.0001), and yield variation from engineered samples was not significant (p=0.3782). Two laboratories failed DNA extraction from samples that may be attributed to operator error. DNA extraction protocols themselves were not found to contribute significant variation. 10/13 labs reported yields averaging 235.8 ng (95% CI 90.7 to 380.9) from cell-negative samples, which was attributed to issues with spectrophotometry. DNA measurements using Qubit Fluorometry demonstrated a median fivefold overestimation of DNA quantity by Nanodrop Spectrophotometry. DNA integrity and PCR inhibition were factors not found to contribute significant variation.
CONCLUSIONS: In this study, we provide evidence demonstrating that variation in pre-PCR steps is prevalent and may detrimentally affect the patient's ability to receive critical therapy. We provide recommendations for preanalytical workflow optimisation that may reduce errors in down-stream sequencing and for next-generation sequencing library generation.
Original language | English |
---|---|
Pages (from-to) | 111-8 |
Number of pages | 8 |
Journal | Journal of Clinical Pathology |
Volume | 68 |
Issue number | 2 |
Early online date | 27 Nov 2014 |
DOIs | |
Publication status | Published - Feb 2015 |
Keywords
- Cell Line, Tumor
- DNA Mutational Analysis
- DNA, Neoplasm
- Diagnostic Errors
- Fixatives
- Fluorometry
- Formaldehyde
- Great Britain
- Humans
- Laboratory Proficiency Testing
- Mutation
- Observer Variation
- Paraffin Embedding
- Polymerase Chain Reaction
- Predictive Value of Tests
- Proto-Oncogene Proteins B-raf
- Receptor, Epidermal Growth Factor
- Reproducibility of Results
- Spectrophotometry
- Tissue Fixation
- Transfection
- United States
- Workflow